Company intelligence / Profile preview

Epicentre Biotechnologies

Madison, Wisconsin, United Statesepicenternow.org ↗

Ownership: Private
Development stage: Other

Overview

Founded in 1987 and based in Madison, Wisconsin, Epicentre Biotechnologies was a leading manufacturer of molecular biology products such as specialty enzymes and nucleic acid sample preparation reagents. Its technologies—most notably Nextera for rapid NGS library prep and Ribo-Zero for ribosomal RNA removal—were widely adopted by academic and commercial labs globally. In January 2011 it was acquired by Illumina to enhance their sample preparation portfolio.

Modalities: EnzymeMolecular biology reagent
Industry: Chemicals & Materials

Beyond the preview

Go deeper on Epicentre Biotechnologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Epicentre Biotechnologies.

Explore the full profile